Previous close | 0.3300 |
Open | 0.3300 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.3131 - 0.3390 |
52-week range | 0.3100 - 1.8600 |
Volume | |
Avg. volume | 123,793 |
Market cap | 5.603M |
Beta (5Y monthly) | 0.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
STONY BROOK, N.Y., May 03, 2023--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release financial results for the three months ended March 31, 2023 after the market close on Thursday, May 11, 2023. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. ET.